<DOC>
	<DOCNO>NCT00809068</DOCNO>
	<brief_summary>Tibolone ( Livial ) show previous study low HDL cholesterol 40 % . This study aim study effect fenofibrate HDL subfractions woman take tibolone .</brief_summary>
	<brief_title>High-density Lipoprotein ( HDL ) Cholesterol Women Taking Tibolone</brief_title>
	<detailed_description>Tibolone decrease plasma concentration HDL cholesterol HDL-apoA1 pre-beta HDL , consistent pro-atherogenic effect . The mechanism tibolone HDL cholesterol suggest result acceleration catabolism HDL stimulation hepatic lipase effect cellular cholesterol efflux . PPAR-a agonist , particular fenofibrate , improve HDL metabolism increase expression hepatic secretion HDL apoAI apoAII . We hypothesise fenofibrate rectify perturbation HDL metabolism work tibolone .</detailed_description>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Tibolone</mesh_term>
	<criteria>Postmenopausal woman More 6 month amenorrhoea Raised FSH low oestradiol level If hysterectomised , raise FSH low oestradiol level Diabetes Renal failure Proteinuria High alcohol intake Regular endurance exercise Active weight loss diet Smokers Agents known influence lipid metabolism Major systemic illness Intolerance tibolone fenofibrate Cholelithiasis CK ALT &gt; 2ULN Bleeding disorder Peptic ulcer disease .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Menopause</keyword>
	<keyword>menopausal symptom</keyword>
	<keyword>tibolone</keyword>
	<keyword>HDL-C</keyword>
	<keyword>fenofibrate</keyword>
</DOC>